Dr Victoria Jane Jackson-Patel

Selected publications and creative works (Research Outputs)

  • Jackson-Patel, V. J. (2018). Inhibiting the Epidermal Growth Factor Receptor (EGFR) to improve clinical outcomes for patients with Squamous Cell Carcinoma of the Head and Neck (SCCHN) The University of Auckland. ResearchSpace@Auckland.
    URL: http://hdl.handle.net/2292/43476
  • Silva, S., Jackson, V., Guise, C., Abbattista, M., Bull, M., Grey, A., ... Pearce, T. (2015). Preclinical efficacy of tarloxotinib bromide (TH­4000), a hypoxia­activated EGFR/HER2 inhibitor: Rationale for clinical evaluation in EGFR mutant, T790M-­negative NSCLC following progression on EGFRTKI therapy. Paper presented at AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics, Boston, Massachusetts. 5 November - 9 November 2015. Molecular Cancer Therapeutics. (pp. 2).
    Other University of Auckland co-authors: Gus Grey, Bob Anderson, Amir Ashoorzadeh, Adam Patterson, Jeff Smaill, Matthew Bull

Contact details

Primary office location

M&HS BUILDING 504 - Bldg 504
Level 0, Room 005
New Zealand